AGREED TO AND ACCEPTED definition

AGREED TO AND ACCEPTED. Witnesses (As to The Artist) --------------------------------- ---------------------------- Xxxxxxx Xxxxxxxx SS # ###-##-#### ____________________________
Sample 1
AGREED TO AND ACCEPTED. Súhlasím a prijímam: NAME/MENO Sub-Investigator / Spoluskúšajúci TITLE / FUNKCIA SIGNATURE/PODPIS DATE / DÁTUM ATTACHMENT G PRÍLOHA G STUDY TEAM PARTICIPANT INVOLVEMENT IN PROTOCOL # - ÚČASŤ ČLENA XXXX XXXXXXXX XX XXXXXXXXX X. (“Sub-Investigator) will be („spoluskúšajúci“) sa zúčastní priebehu skúšania vo vyššie uvedenom protokole. involved in the conduct of the Trial for the above referenced Protocol. Participation in the Trial is subject to INC Research’s prior written approval. Účasť na skúšaní musí byť predtým písomne schválená spoločnosťou INC Research. Sub-Investigator represents and warrants that she: Spoluskúšajúci vyhlasuje a zaručuje, že: - is an experienced health care professional; – je skúsený zdravotnícky pracovník, - will keep in strict confidence all study related documents and all study related information; – celú dokumentáciu a všetky informácie spojené so skúšaním bude udržiavať v prísnej tajnosti, - if not provided by the Principal Investigator, she will obtain a copy of the Protocol and its amendments (if any) – zadováži kópiu protokolu a jeho prípadných dodatkov, ak ich neposkytne zodpovedný skúšajúci, - will strictly adhere to the Protocol and its amendments (if any); – bude striktne dodržiavať protokol a jeho prípadné dodatky, -she has read the Principal Investigator’s obligations under the present Clinical Trial Agreement and agrees to comply with these obligations (including but not limited to the obligations of Confidentiality, Inventions, compliance with Applicable Law, Protocol, Insurance) to the extent that these obligations relate to Sub-Investigator’s performance under this Agreement; – si prečítala povinnosti zodpovedného skúšajúceho vyplývajúce z tejto zmluvy o klinickom skúšaní a zaväzuje sa ich dodržiavať (vrátane povinností týkajúcich sa zachovávania mlčanlivosti, vynálezov, dodržiavania príslušných právnych predpisov, protokolu, poistenia), a to do rozsahu, do akého sa tieto povinnosti týkajú plnenia spoluskúšajúceho skúšania podľa tejto zmluvy, - will work under the supervision and direction of the Principal Investigator and will comply with the Principal Investigator’s instructions; – bude pracovať pod dohľadom a vedením zodpovedného skúšajúceho a bude dodržiavať jeho pokyny, - has obtained all the necessary approvals and has made the necessary notifications to the Institution in accordance with any applicable employment regulations regarding the performance of her services under the present Clinical Trial Agreement;...
Sample 1
AGREED TO AND ACCEPTED. PURCHASER: VISTERRA, INC. [Name] By: By: Name: Name: Title: Title: Date: , 2016 Date: , 2016 SCHEDULE 1 PURCHASERS Name and Contact Information Number of Series C Shares Purchase Price for Series C Shares and Warrants Merck Sharp & Dohme Corp. Xxx Xxxxx Xxxxx X.X. Xxx 000 Xxxxxxxxxx Xxxxxxx, XX 00000 Attn: Office of the Secretary Email: 3,448,276 $ 5,000,000.20 Vertex Global Healthcare Fund I Pte. Ltd. 000 Xxxxx Xxxxxx Xxxx #00-00 Xxxxxxx Xxxx Xxxxx Xxxxxxxxx 000000 Email: 3,448,276 $ 5,000,000.20 Polaris Venture Partners V, L.P. Bay Colony Corporate Center 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxx, XX 00000 Attention: Email: 2,329,151 $ 3,377,268.95 Polaris Venture Partners Entrepreneurs’ Fund V, L.P. Bay Colony Corporate Center 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxx, XX 00000 Attention: Email: 45,395 $ 65,822.75 Polaris Venture Partners Founders’ Fund V, L.P. Bay Colony Corporate Center 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxx, XX 00000 Attention: Email: 15,955 $ 23,134.75 Polaris Venture Partners Special Founders’ Fund V, L.P. Bay Colony Corporate Center 0000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxxx, XX 00000 Attention: Email: 23,292 $ 33,773.40 Flagship Ventures Fund IV, L.P. Xxx Xxxxxxxx Xxxxx 0xx Xxxxx Xxxxxxxxx, XX 00000 Email: 1,931,034 $ 2,799,999.30 Flagship Ventures Fund IV-Rx, L.P. Xxx Xxxxxxxx Xxxxx 0xx Xxxxx Xxxxxxxxx, XX 00000 Email: 482,759 $ 700,000.55 CTI Life Sciences 0 Xxxxx Xxxxx-Xxxxx, Bureau 1050 Montréal (Québec) H3B 4S6 1,379,310 $ 1,999,999.50 Cycad Group, LLC 0000 Xxxxx Xxxxxxx Xxxxxx, Xxxxx 000 Xxxxx Xxxxxxx, XX 00000 Attn: 1,034,483 $ 1,500,000.35 Omega Cambridge SPV, L.P. USA Credit Suisse Securities (USA), LLC 0 Xxxxxxx Xxxxxx, 00xx Xxxxx Xxxxxx, XX 00000 Attention: Email: 689,655 $ 999,999.75 Alexandria Equities 000 X. Xxxxxxxx Xxxxxxxxx, Xxxxx 000 Xxxxxxxx, XX 00000 Attention: Email: 344,828 $ 500,000.60 Xxxx Xxxxx Email: 344,828 $ 500,000.60 Weidenbruch Family Trust Dated 11/24/2009 Email: 137,931 $ 199,999.95 Xxxxx Xxxxxxx Email: 275,862 $ 399,999.90
Sample 1Sample 2

Examples of AGREED TO AND ACCEPTED in a sentence

  • EMPLOYER: [Insert Name of Employer] By: Date: [Insert Name] [Insert Title] AGREED TO AND ACCEPTED.

  • The technical specifications are located at xxx.xxxxxxxxxx.xxx under the heading “Information” and subheading “Technical Specifications.” SEE ATTACHED FACILITY USE ESTIMATE OF COSTS AGREED TO AND ACCEPTED BY: FOR: (User/Organization) BY: King Center for the Performing Arts, Inc.

  • AGREED TO AND ACCEPTED: Please sign and return to Lending Institution.

  • AGREED TO AND ACCEPTED THIS 27th DAY OF JUNE, 2013: FOR THE UNIVERSITY: Xxxxx X.

  • THE FOREGOING TERMS ARE AGREED TO AND ACCEPTED BY: PERFORMING PARTY Signature Date Street City State Zip Code For Performing Party who is signing this Agreement as an individual, initial below: By initialing here , I represent that I am a citizen or a U.S. Lawful Permanent Resident of the United States.


More Definitions of AGREED TO AND ACCEPTED

AGREED TO AND ACCEPTED. AGREED TO AND ACCEPTED: GENIUS PRODUCTS, INC., Licensee FALCON PICTURE GROUP, LLC, Falcon /s/ Xxxxx Xxxxxxx /s/ Xxxx Xxxxx -------------------------------------- ----------------------------------- Xxxxx Xxxxxxx, Chief Executive Officer Xxxx Xxxxx, Chief Executive Officer EXHIBIT A NOTICES REGARDING COMMON STOCK ISSUANCES THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED WITH ANY STATE SECURITIES OR FEDERAL REGULATORY AGENCY, AND NO STATE OR FEDERAL REGULATORY AGENCY HAS PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF ANY DISCLOSURE MADE IN CONNECTION THEREWITH. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. THE SECURITIES OFFERED HEREBY MAY NOT BE RESOLD WITHOUT REGISTRATION UNDER APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO GENIUS PRODUCTS, INC. IS OBTAINED TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER SUCH LAWS. XXXX XXXXX ("INVESTOR") ACKNOWLEDGES THAT THE COMMON STOCK HAS NOT BEEN REGISTERED UNDER THE FEDERAL SECURITIES LAWS, THE CALIFORNIA CORPORATE SECURITIES LAW OR THE SECURITIES LAWS OF NEVADA OR ANY OTHER STATE. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND THEY MAY NOT BE OFFERED, SOLD OR TRANSFERRED UNLESS AND UNTIL SUCH SECURITIES ARE REGISTERED UNDER APPLICABLE FEDERAL AND STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION IS OBTAINED TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER SUCH LAWS. INVESTOR'S ACCEPTANCE OF THE COMMON STOCK CONSTITUTES A SPECULATIVE, HIGH-RISK INVESTMENT THAT SHOULD BE ACCEPTED ONLY IF INVESTOR IS ABLE TO AFFORD THE LOSS OF ITS ENTIRE INVESTMENT. THE SUITABILITY OF THIS TYPE OF INVESTMENT SHOULD BE EXAMINED IN THE CONTEXT OF INVESTOR'S OWN NEEDS, INVESTMENT OBJECTIVES AND FINANCIAL CAPABILITIES, AND INVESTOR SHOULD MAKE AN INDEPENDENT INVESTIGATION AND DECISION AS TO THE SUITABILITY OF THIS INVESTMENT AND AS TO THE RISKS AND POTENTIAL LOSSES INVOLVED. INVESTOR IS ENCOURAGED TO CONSULT WITH ITS ATTORNEYS, ACCOUNTANTS, FINANCIAL CONSULTANTS AND OTHER BUSINESS AND TAX ADVISORS REGARDING THE RISKS AND MERITS OF THE INVESTMENT. EXHIBIT B XXXX XXXXX REPRESENTATIONS AND WARRANTIES
Sample 1Sample 2
AGREED TO AND ACCEPTED. PURCHASER: VISTERRA, INC. [Name] By: By: Name: Name: Title: Title: Date: , 2014 Date: , 2014 SCHEDULE 1 FIRST CLOSING Name Number of First Closing Series B Shares Purchase Price for First Closing Series B Shares Number of Common Shares Merck Sharp & Dohme Corp. 6,000,000 $ 7,500,000 1,500,000 Polaris Venture Partners V, L.P. 2,782,783 $ 3,478,478.75 695,695 Polaris Venture Partners Entrepreneurs’ Fund V, L.P. 54,236 $ 67,795.00 13,559 Polaris Venture Partners Founders’ Fund V, L.P. 19,062 $ 23,827.50 4,765 Polaris Venture Partners Special Founders’ Fund V, L.P. 27,828 $ 34,785.00 6,957 S1-1 Name Number of First Closing Series B Shares Purchase Price for First Closing Series B Shares Number of Common Shares Flagship Ventures Fund IV, L.P. 2,092,890 $ 2,616,112.50 523,222 Flagship Ventures Fund IV-Rx, L.P. 523,223 $ 654,028.75 130,805 Omega Cambridge SPV, L.P. 383,315 $ 479,143.75 95,828 Alexandria Equities, LLC 76,663 $ 95,828.75 19,165 Xxxxx X X Xxxxxxx 40,000 $ 50,000.00 10,000 TOTAL 12,000,000 $ 15,000,000 2,999,996 SECOND CLOSING Name Number of Second Closing Series B Shares Purchase Price for Second Closing Series B Shares Number of Common Shares Merck Sharp & Dohme Corp.* 2,000,000 $ 2,500,000.00 500,000 Cycad Group, LLC 1,400,000 $ 1,750,000.00 350,000 Polaris Venture Partners V, L.P.* 186,868 $ 233,585.00 46,717 Polaris Venture Partners Entrepreneurs’ Fund V, L.P.* 3,642 $ 4,552.50 910 Polaris Venture Partners Founders’ Fund V, L.P.* 1,280 $ 1,600.00 320 Polaris Venture Partners Special Founders’ Fund V, L.P.* 1,869 $ 2,336.25 467 Flagship Ventures Fund IV, L.P.* 140,541 $ 175,676.25 35,135 Flagship Ventures Fund IV-Rx, L.P.* 35,135 $ 43,918.75 8,783 Omega Cambridge SPV, L.P.* 25,554 $ 31,942.50 6,388 Alexandria Equities, LLC* 5,111 $ 6,388.75 1,277 V-Sciences Investment Pte Ltd 5,200,000 $ 6,500,000.00 1,300,000 Name Number of Second Closing Series B Shares Purchase Price for Second Closing Series B Shares Number of Common Shares Vertex USA Fund Pte. Ltd. 2,800,000 $ 3,500,000.00 700,000 Xxxxx Xxxxxxx* 40,000 $ 50,000.00 10,000 Xxxxx Xxxxxxxx 24,000 $ 30,000.00 6,000 Xxxxx Xxxxxxx 136,000 $ 170,000.00 34,000 TOTAL 12,000,000 $ 15,000,000.00 2,999,997 * Address shown above EXHIBIT A Form of Restated Certificate AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF VISTERRA, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Visterra, Inc., a corporation organized and existing under and by virtue of the pro...
Sample 1Sample 2
AGREED TO AND ACCEPTED. XXXX COMMUNICATIONS SYSTEMS, INC. By: Title: Number of Shares Exercised: Number of Shares Remaining: Date:
Sample 1Sample 2
AGREED TO AND ACCEPTED. S1 CORPORATION By: /s/ Jxxxxx Xxxxxx President and Chief Executive Officer
Sample 1
AGREED TO AND ACCEPTED. Witnesses (As to Writer) ------------------------------ ----------------------------- Alex Acosta SS: _____________________________
Sample 1
AGREED TO AND ACCEPTED. ("Network") ("Licensor") XXXX Network, Inc., dba America One Television Omni Broadcasting Network, Inc. By: XXXX Network, Inc By: /s/ Xxx Xxxx By: /s/ Xxxxx Xxxx Xxxxx Name: Xxx Xxxx Name: Xxxxx Xxxx Xxxxx Title: General Manager Title: Chief Executive Officer EXHIBIT "A" TERMS AND CONDITIONS TO PROGRAM LICENSE AGREEMENT A-1. GRANT: Licensor hereby grants to Network the right and license to distribute, transmit, broadcast, advertise, promote, project and perform the Program(s) listed in this Agreement through it's affiliates, on broadcast an cable television only. The aforementioned rights and license is limited to the United States, and its possessions. Network will provide Licensor a list of affiliates that are carrying Licensors programming. Licensor may list these individual stations as clearing the program as long as such listing identifies such stations as being affiliates of America One.
Sample 1
AGREED TO AND ACCEPTED. AGREED TO AND ACCEPTED: /s/ Xxxxxx Xxxxxx /s/ Xxxxx Xxxxxxxxxx ----------------------------------- ----------------------------------- Xxxxxx Xxxxxx Adelphia Communications Corporation Name: Xxxxx Xxxxxxxxxx January 17, 2003 Title: Chairman and Interim Chief Executive Officer January 17, 2003
Sample 1